source clinicalSource Clinical is an invaluable guide to the clinical research services sector, supporting pharmaceutical and biotechnology companies with the information they need to progress their drug candidates through the clinical development process.

Source Clinical comprises an extensive compilation of information on companies with the expertise to support and manage clinical research including suppliers of clinical trial quantities of drug products, contract test laboratories, operators of clinical research facilities and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

Through its comprehensive coverage, and with the support of One Nucleus and Bionow, Source Clinical is the reference tool supplying essential information that streamlines the clinical research partner selection process.

TrakCel and The Quick Life Science Group partner on supply chain IT solution for cell and gene therapies

TrakCel logo 19.1.19Quick logo 19.1.19Cell and gene therapy supply chain tracking software specialist TrakCel and The Quick Life Science Group have formed a partnership to offer an integrated IT logistics orchestration platform that enables cell and gene therapy companies to track products and manage the logistical processes of each needle-to-needle supply chain through a single interface. The platform enables automatic scheduling of activities across multiple supply chain partners, product-specific workflows to ensure consistent handling and execution of tasks, and validated chain-of-identity tracking to guarantee correct drug product delivery for clinics and manufacturing sites in North America and Europe.

According to the Alliance for Regenerative Medicine, there are 892 companies and 1003 industry-sponsored clinical trials underway worldwide utilising regenerative medicine and advanced cell therapy technologies. As a result, the volume and growth of clinical and commercial products is increasing the workload for all stakeholders across the supply chain including clinical sites, apheresis collection centres, manufacturing facilities and couriers. In addition, individual cell and gene therapy supply chains face unique complexities such as precise scheduling requirements and the need to transport temperature and time-sensitive materials globally. Therefore, a combination of these factors increases the necessity for control and visibility of the timing of sample collection through to product infusion and the new collaboration between TrakCel and Quick has been formed to address this.

For further information about TrakCel visit and for further information about The Quick Group visit

Last modified onThursday, 31 January 2019 13:48